| Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections HA Parray, S Shukla, R Perween, R Khatri, T Shrivastava, V Singh, ... Applied Microbiology and Biotechnology 105 (16), 6315-6332, 2021 | 67 | 2021 |
| Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus P Murugavelu, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ... International immunopharmacology 99, 108020, 2021 | 17 | 2021 |
| A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern HA Parray, N Narayanan, S Garg, ZA Rizvi, T Shrivastava, S Kushwaha, ... PLOS Pathogens 18 (12), e1010994, 2022 | 8 | 2022 |
| The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41 R Perween, M PraveenKumar, T Shrivastava, HA Parray, V Singh, ... International Immunopharmacology 101, 108187, 2021 | 7 | 2021 |
